BX-004

N/A

Report date: 2025/07/16 11:53:39

Base Information

Drug NameBX-004
Drug Alias NameBX-004BX004-A
ClassificationBiologics > Bacteriophages
Mechanisms of ActionCell death stimulants
TargetsNot applicable
Therapy Area/IndicationsPseudomonas aeruginosa pneumoniaCystic FibrosisPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesNetherlands +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiomX Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomX LtdBiomX Inc
Inactive CompaniesN/A
Active IndicationsPseudomonas aeruginosa pneumoniaCystic Fibrosis
Inactive IndicationsPseudomonas Infections

Other Information

ATC CodeN/A
Related LinksN/A